(PCRX) |
| 0 (0%) 01-14 16:27 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 27.16 |
| Resistance 1: | 24.94 |
| Pivot price: | 24.91 |
| Support 1: | 21.35 |
| Support 2: | 17.76 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.470 |
| Book Value | 16.920 |
| PEG Ratio | 0.00 |
| Gross Profit | 10.940 |
| Profit Margin (%) | 2.99 |
| Operating Margin (%) | 7.33 |
| Return on Assets (ttm) | 2.9 |
| Return on Equity (ttm) | 2.9 |
Company news
Wed, 14 Jan 2026
PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific - Zacks Investment Research
Tue, 13 Jan 2026
Opioid-sparing EXPAREL to reach patients in South Korea and Thailand - Stock Titan
Tue, 13 Jan 2026
Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 29.59% Potential Upside in Non-Opioid Pain Management Solutions - DirectorsTalk Interviews
Tue, 13 Jan 2026
Behavioral Patterns of PCRX and Institutional Flows - Stock Traders Daily
Mon, 12 Jan 2026
Pacira BioSciences (PCRX) Is Down 6.3% After Cut 2025 Outlook And Activist Pressure - Has The Bull Case Changed? - simplywall.st
Mon, 12 Jan 2026
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates - Prime Publishers, Inc.
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
